Raising Awareness of Pulmonary Fibrosis

Did you know that pulmonary fibrosis takes as many lives as breast cancer or prostate cancer? However, unlike breast and prostate cancer, there is no remission and treatment can only ease the symptoms. Around 40,000 people die each year from pulmonary fibrosis in the U.S. yet very few people…

A University of Vermont medical professor has won a $6.3 million award to study antioxidant therapy as a possible treatment option for those with lung diseases such as pulmonary fibrosis (PF) and asthma. The National Heart, Lung, and Blood Institute (NHLBI) gave its first Outstanding…

A single microRNA was found to play a key role in lung fibrosis by regulating several signaling pathways involved in the release of pro-fibrotic signals. The study, “miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways,” was published in the journal JCI Insight. MicroRNAs are small…

There is so much to adjust to when you’ve been diagnosed with pulmonary fibrosis. For me the biggest adjustment has been the diagnosis itself, with it’s dismal future. Then there’s medical tests, oxygen, tiredness, change in functioning at home and work, grief, and a…

The Viscira production company has won an international award for a 3D animated video about idiopathic pulmonary fibrosis (IPF) that it did in collaboration with Roche. The Academy of Interactive and Visual Arts gave its Silver Davey Award to Viscira for the best video in its category. The Davey…

Fat-free mass index (FFMI), a measure similar to body mass index (BMI) but that also takes into account the amount of muscle mass in the body is a significant predictor of survival in idiopathic pulmonary fibrosis (IPF) patients.

This film from Focus Patient describes the rare chronic lung disease idiopathic pulmonary fibrosis (IPF) for patients who have been recently diagnosed. Dr. Toby Maher talks about how doctors discuss idiopathic pulmonary fibrosis with their newly diagnosed patients. The educational film goes into detail about how the lungs work…

Exercise is crucial for people with pulmonary fibrosis to help slow down the decline of lung function and to maintain overall health, but over the holidays it can be difficult to find the time. With this in mind, we’ve put together a list of tips to help you find time to…

Wide access to potential molecular drug targets to treat pulmonary fibrosis is now possible, as researchers have mapped the complete set of genes active in individual lung cells from patients with idiopathic lung fibrosis and from healthy people. The analysis, called single-cell RNA sequencing, also made it possible to single out several…

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease caused by scarring of the lung tissue. It’s classed as an interstitial lung disease and is very rare. While there is no definitive cause for IPF, there are many reasons why a person may be more likely to develop the…